Advancing Personalized Care for Prostate Cancer: Patient-Centered Solutions for mHSPC and nmCRPC Authors: Alicia K. Morgans, MD, MPH, FASCO; Christian Gratzke, MD; Fred Saad, MD, FRCS, FCAHS; Tony Collier, BEM

https://www.medscape.org/viewarticle/advancing-personalized-care-prostate-cancer-patient-centered-2025a1000uyb?page=1&uac=148436CN&sso=true&src=mkmcmr_driv_stan_mscpedu_260301-OUS-HONC-advancing-personalized-care-prostate-cancer-patient-centered-2025a1000uyb-cta

Current and Future Oral SERD Strategies in the Management of ER-Positive/HER2-Negative MBC: Analyzing the Clinical Data Authors: Komal Jhaveri, MD, FACP, FASCO; Shaheenah Dawood, MD, MPH

https://www.medscape.org/viewarticle/current-and-future-oral-serd-strategies-management-er-2026a100022b?page=1&uac=148436CN&src=mkmcmr_driv_stan_mscpedu_260301-OUS-HONC-current-and-future-oral-serd-strategies-management-er-2026a100022b-cta&sso=true

Immunotherapy Remains Little Used in Head and Neck Cancer Edited by Amy Norton March 02, 2026 ++++

https://www.medscape.com/viewarticle/immunotherapy-remains-little-used-head-and-neck-cancer-2026a10006cp MRI-Guided Chemotherapy Duration Yields Favourable Survival Outcomes in Patients With HER2-Positive Breast Cancer Edited by Vineeta Teotia https://www.medscape.com/viewarticle/mri-guided-chemotherapy-duration-yields-favourable-survival-2026a100062k Medscape UK March 02, 2026 Global Study Supports Meat-Free Diets for Cancer Prevention Ernie Mundell https://www.medscape.com/viewarticle/global-study-supports-meat-free-diets-cancer-prevention-2026a10006do March 02, 2026 Bannwarth Syndrome in a Woman With Early Breast Cancer Wolfgang Paik https://www.medscape.com/viewarticle/bannwarth-syndrome-woman-early-breast-cancer-2026a10006br March 02, 2026

Enhancing Impactful Patient-Centered Care for NMSC Through Meaningful Connections Authors: Dirk Schadendorf, MD; Emily Ruiz, MD, MPH

https://www.medscape.org/viewarticle/1002953?uac=148436CN&src=mkmcmr_driv_stan_mscpedu_260302-OUS-HONC-1002953-cta&sso=true

Psoriasis: Addressing Weight Loss in Patients | How Biologics Continue to Transform Dermatologic Care +++++ +

Weight Loss and Psoriasis: How to Talk With Patients and Take a Comprehensive Approach Christine Kilgore https://www.medscape.com/viewarticle/weight-loss-and-psoriasis-how-talk-patients-and-take-2026a100023y?ecd=mkm_ret_260302_mscpmrk-OUS_InFocus_etid8138823&uac=148436CN&impID=8138823 January 22, 2026 Bimekizumab Eases Plaque Psoriasis Symptoms Up to 3 Years Edited by Deepa Varma https://www.medscape.com/viewarticle/bimekizumab-eases-plaque-psoriasis-symptoms-3-years-2026a100052j?ecd=mkm_ret_260302_mscpmrk-OUS_InFocus_etid8138823&uac=148436CN&impID=8138823 February 18, 2026 Biologics Continue to Transform Dermatology, With Safer and More Effective Care Damian McNamara, MA https://www.medscape.com/viewarticle/biologics-continue-transform-dermatology-safer-and-more-2026a10004du?ecd=mkm_ret_260302_mscpmrk-OUS_InFocus_etid8138823&uac=148436CN&impID=8138823 February 11, 2026 Pediatric Psoriasis Lacks Clear Guidance for Everyday Care Caroline Guignot https://www.medscape.com/viewarticle/pediatric-psoriasis-lacks-clear-guidance-everyday-care-2026a10001iq?ecd=mkm_ret_260302_mscpmrk-OUS_InFocus_etid8138823&uac=148436CN&impID=8138823 Medscape Europe January 16, 2026 Biologic Plus GLP-1 Agonist Improves Quality of Life in Psoriatic Disease Ted Bosworth https://www.medscape.com/viewarticle/biologic-plus-glp-1-agonist-improves-quality-life-psoriatic-2026a10002s0?ecd=mkm_ret_260302_mscpmrk-OUS_InFocus_etid8138823&uac=148436CN&impID=8138823 January 28, 2026 Patient with plaque psoriasis asking about a study mentioned in online support group about high dose risankizumab. What is the latest? (Medscape AI) https://www.medscape.com/ai-search?query=Patient%20with%20plaque%20psoriasis%20asking%20about%20a%20study%20mentioned%20in%20online%20support%20group%20about%20high%20dose%20risankizumab.%20What%20is%20the%20latest%3F&&ecd=mkm_ret_260302_mscpmrk-OUS_InFocus_etid8138823&uac=148436CN&impID=8138823

Drug Trials Snapshots: EXDENSUR - EXDENSUR (depemokimab)

https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-exdensur EXDENSUR is a medication that is approved for the add-on maintenance treatment of severe asthma characterized by an eosinophilic phenotype in adult and pediatric patients aged 12 years and older.

Drug Trials Snapshots: KOMZIFTI - KOMZIFTI (ziftomenib)

https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-komzifti KOMZIFTI is a cancer drug that is used to treat adult patients with acute myeloid leukemia (AML) with a susceptible nucleophosmin 1 (NPM1) mutation that has come back or has not improved after previous treatment(s) and who have no satisfactory alternative treatment options.